Cargando…

Anti-inflammatory effect of procalcitonin on in vitro LPS-stimulated human PBMC

Detalles Bibliográficos
Autores principales:	Foca, A, Quirino, A, Pulicari, MC, Rametti, L, Matera, G, Liberto, MC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254945/ http://dx.doi.org/10.1186/cc9130

Ejemplares similares

Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells
por: Matera, Giovanni, et al.
Publicado: (2012)

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients
por: Focà, A, et al.
Publicado: (2012)

Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study
por: Matera, Giovanni, et al.
Publicado: (2013)

Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
por: Quirino, Angela, et al.
Publicado: (2014)

Multicolor flow cytometry analysis of innate responses following in vitro interaction of PBMC with Hepatitis C virus
por: Gondois-Rey, Françoise, et al.
Publicado: (2010)

The anti-inflammatory stage of monocytes after long-term stimulation with LPS is mediated by p38 MAP kinase dependent epigenetic silencing
por: Viemann, D, et al.
Publicado: (2008)

Lipopolysaccharides: From Erinyes to Charites
por: Focà, Alfredo, et al.
Publicado: (2012)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Does the number of apoptotic cells in PBMC reveal the extent of impairment in T cell functionality?
por: Sundararaman, Srividya, et al.
Publicado: (2013)

Optimization of antibiotic therapy by procalcitonin
por: Popov, D, et al.
Publicado: (2009)

PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
por: Lepone, Lauren, et al.
Publicado: (2014)

Discriminative procalcitonin values for diagnosis of systemic inflammatory response syndrome and sepsis in the ICU
por: Gharsallah, H, et al.
Publicado: (2008)

Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study
por: Foca, A, et al.
Publicado: (2014)

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
por: Chenine, A, et al.
Publicado: (2009)

Exploring the translational disconnect between the murine and human inflammatory response: in vitro analysis of the dose-response relationship of LPS and NFκB activation in murine and human immune cells
por: McCarron, EP, et al.
Publicado: (2013)

Histone acetyltransferase and DNA methyltransferase expression in response to LPS stimulation
por: Rios, Ester Correia Sarmento, et al.
Publicado: (2013)

SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients
por: Siccardi, M, et al.
Publicado: (2010)

Elevation of procalcitonin in chronic dialysed patients
por: Brodska, H, et al.
Publicado: (2008)

Procalcitonin as prognostic marker of mortality
por: Zampieri, S, et al.
Publicado: (2013)

Evaluation of procalcitonin in patients with sepsis in Albanian adults
por: Puca, E, et al.
Publicado: (2012)

MSM enhances LPS-induced inflammatory response after exercise
por: Godwin, Simone, et al.
Publicado: (2015)

Serum procalcitonin as a diagnostic tool of bacteremia
por: Gartzonika, C, et al.
Publicado: (2010)

Can procalcitonin reflect the etiology of the bacteremia?
por: Chernevskaya, Ekaterina, et al.
Publicado: (2007)

Procalcitonin, cytokine and NOx in diabetic ketoacidosis
por: Suwarto, S, et al.
Publicado: (2008)

Predictive value of procalcitonin and IL-6 for postoperative sepsis
por: Marx, G, et al.
Publicado: (2005)

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
por: Brown, BK, et al.
Publicado: (2009)

Use of procalcitonin as an aid to antibiotic prescribing in intensive care
por: Fletcher, A, et al.
Publicado: (2008)

Evaluation of procalcitonin at James Paget Intensive Care Unit
por: Brodbeck, A, et al.
Publicado: (2010)

A translational approach to test anti-inflammatory drugs in a LPS induced acute lung inflammation model in the common marmoset (Callithrix jacchus)
por: Seehase, S, et al.
Publicado: (2013)

G-CSF is an endothelial survival factor in LPS-induced inflammatory conditions
por: Schneider, M, et al.
Publicado: (2006)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Diagnostic value of procalcitonin monitoring in cardiac surgery
por: Beloborodova, N, et al.
Publicado: (2004)

Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)

The prognostic value of procalcitonin in cardiac surgical patients
por: Iasonidou, C, et al.
Publicado: (2005)

Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009)

Role of procalcitonin in diagnostics of acute adrenal insufficiency
por: Popugaev, K, et al.
Publicado: (2008)

The change of procalcitonin concentrations after tracheostomy at bedside
por: Sato, K, et al.
Publicado: (2015)

Diagnostic accuracy of procalcitonin in proven and clinically suspected systemic infection
por: Das, S, et al.
Publicado: (2012)

The utility of procalcitonin for the patients with infected pancreatic necrotic and pancreatic abscess
por: Adachi, T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oksjec7ctg90nom6r1ovhh7l18